{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:14:13Z","timestamp":1776114853847,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23890008"],"award-info":[{"award-number":["23890008"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bone.2014.10.027","type":"journal-article","created":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T11:02:32Z","timestamp":1415444552000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis"],"prefix":"10.1016","volume":"71","author":[{"given":"Yusuke","family":"Kameda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Mikuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Angata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigetsugu","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Kinjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimasa","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.10.027_bb0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1172\/JCI16923","article-title":"Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice","volume":"111","author":"Kaifu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.10.027_bb0010","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature02444","article-title":"Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis","volume":"428","author":"Koga","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bone.2014.10.027_bb0015","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1359\/JBMR.0301234","article-title":"The signaling adapter protein DAP12 regulates multinucleation during osteoclast development","volume":"19","author":"Humphrey","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.027_bb0020","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1073\/pnas.0401602101","article-title":"The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase","volume":"101","author":"Mocsai","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2014.10.027_bb0025","doi-asserted-by":"crossref","first-page":"17493","DOI":"10.1074\/jbc.M111.324194","article-title":"Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12kDa (DAP12)","volume":"287","author":"Ishida-Kitagawa","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.10.027_bb0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1359\/JBMR.051016","article-title":"TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function","volume":"21","author":"Humphrey","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.027_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4049\/jimmunol.164.1.9","article-title":"Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells","volume":"164","author":"Dietrich","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2014.10.027_bb0040","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1073\/pnas.96.17.9792","article-title":"Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells","volume":"96","author":"Bakker","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2014.10.027_bb0045","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","article-title":"The TREM receptor family and signal integration","volume":"7","author":"Klesney-Tait","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bone.2014.10.027_bb0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20090516","article-title":"Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritis","volume":"207","author":"Joyce-Shaikh","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.bone.2014.10.027_bb0055","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/jbmr.1989","article-title":"Siglec-15 regulates ssteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase\/Akt and Erk pathways in association with signaling adaptor DAP12","volume":"28","author":"Kameda","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.027_bb0060","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1074\/jbc.M113.494542","article-title":"Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption","volume":"289","author":"Stuible","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.10.027_bb0065","doi-asserted-by":"crossref","first-page":"13960","DOI":"10.1073\/pnas.251534698","article-title":"Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo","volume":"98","author":"Roggia","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2014.10.027_bb0070","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1359\/jbmr.1997.12.6.935","article-title":"The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice","volume":"12","author":"Kimble","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.027_bb0075","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1172\/JCI119333","article-title":"Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency","volume":"99","author":"Ammann","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.10.027_bb0080","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1210\/endo.143.3.8701","article-title":"TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL","volume":"143","author":"Fuller","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.10.027_bb0085","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1074\/jbc.275.7.4858","article-title":"Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts","volume":"275","author":"Azuma","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.10.027_bb0090","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/glycob\/cwm049","article-title":"Siglec-15: an immune system Siglec conserved throughout vertebrate evolution","volume":"17","author":"Angata","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.bone.2014.10.027_bb0095","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.027_bb0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.027_bb0105","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1359\/jbmr.2000.15.8.1477","article-title":"Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts","volume":"15","author":"Takeshita","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.027_bb0110","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.4049\/jimmunol.165.8.4254","article-title":"Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor","volume":"165","author":"Kaneda","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2014.10.027_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bone.2007.03.016","article-title":"Sialylation of cell surface glycoconjugates is essential for osteoclastogenesis","volume":"41","author":"Takahata","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.10.027_bb0120","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha","volume":"106","author":"Cenci","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.10.027_bb0125","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1172\/JCI45913","article-title":"OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice","volume":"121","author":"Barrow","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.10.027_bb0130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7150\/ijms.5180","article-title":"Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspective","volume":"9","author":"Zhao","year":"2012","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.bone.2014.10.027_bb0135","doi-asserted-by":"crossref","unstructured":"Hiruma Y, Tsuda E, Maeda N, Okada A, Kabasawa N, Miyamoto M, et al. Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice. Bone 53: 87\u201393.","DOI":"10.1016\/j.bone.2012.11.036"},{"key":"10.1016\/j.bone.2014.10.027_bb0140","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1242\/jcs.069872","article-title":"Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts","volume":"123","author":"Zou","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bone.2014.10.027_bb0145","doi-asserted-by":"crossref","first-page":"e586","DOI":"10.1371\/journal.pone.0000586","article-title":"Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency","volume":"2","author":"Wu","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2014.10.027_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nri2014","article-title":"Activating and inhibitory functions of DAP12","volume":"7","author":"Turnbull","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bone.2014.10.027_bb0155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ni1204","article-title":"Enhanced toll-like receptor responses in the absence of signaling adaptor DAP12","volume":"6","author":"Hamerman","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bone.2014.10.027_bb0160","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","article-title":"Cutting edge: TREM-2 attenuates macrophage activation","volume":"177","author":"Turnbull","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2014.10.027_bb0165","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.177.4.2051","article-title":"Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12","volume":"177","author":"Hamerman","year":"2006","journal-title":"J Immunol"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214004013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214004013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:39:25Z","timestamp":1757612365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214004013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":33,"alternative-id":["S8756328214004013"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.10.027","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}